Co-Diagnostics, Inc. (CODX)
NASDAQ: CODX · Real-Time Price · USD
1.180
-0.030 (-2.48%)
At close: Nov 7, 2024, 4:00 PM
1.190
+0.010 (0.85%)
After-hours: Nov 7, 2024, 5:19 PM EST
Co-Diagnostics Market Cap
Co-Diagnostics has a market cap or net worth of $37.65 million as of November 7, 2024. Its market cap has increased by 12.07% in one year.
Market Cap
37.65M
Enterprise Value
-3.69M
1-Year Change
12.07%
Ranking
Category
Stock Price
$1.18
Market Cap Chart
Since July 12, 2017, Co-Diagnostics's market cap has decreased from $65.00M to $37.65M, a decrease of -42.07%. That is a compound annual growth rate of -7.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2024 | 38.60M | -5.16% |
| Dec 29, 2023 | 40.70M | -47.75% |
| Dec 30, 2022 | 77.90M | -69.81% |
| Dec 31, 2021 | 258.00M | -1.86% |
| Dec 31, 2020 | 262.90M | 1,596.13% |
| Dec 31, 2019 | 15.50M | -19.27% |
| Dec 31, 2018 | 19.20M | -40.74% |
| Dec 29, 2017 | 32.40M | -50.15% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ProPhase Labs | 41.78M |
| NeueHealth | 40.91M |
| Apyx Medical | 40.19M |
| Lexaria Bioscience | 39.79M |
| OKYO Pharma | 39.25M |
| CareCloud | 38.59M |
| Surrozen | 38.09M |
| Passage Bio | 37.34M |